CAMBRIDGE, Mass., June 2, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative drug discovery and development company, today announced that Adelene Q. Perkins, President and Chief Executive Officer, will present a company overview at the Jefferies 2010 Global Life Sciences Conference on Wednesday, June 9, 2010 at 3:30 p.m. EDT in New York City.
A live webcast of Infinity's presentation will be accessible on the company's website at http://www.infi.com and will be archived on the website for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for difficult to treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity's programs in the inhibition of the Hsp90 chaperone system, the Hedgehog pathway and fatty acid amide hydrolase are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company's website at http://www.infi.com.